Summary | Selective Hsp90ß inhibitors for the treatment of cancer

Crowdsourcing scientists around the world with orphan and dormant intellectual property (IP).

Join Us Sign In

This is the pilot version of Therapoid. Register or Sign in as a pilot user to collaborate.

Provided by: The Center for Advancing Innovation ; University of Kansas
Tags: molecular chaperone Hsp90ß Hsp90ß inhibitors anti-cancer

Short Description:

This technology pertains to highly selective Hsp90ß inhibitors that can be developed for the treatment of a variety of diseases that result from increased Hsp90 expression.

Projects based on this Technology

Start New Project